U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from dbVar

    • Showing Current items.

    BRCA1 BRCA1 DNA repair associated [ Homo sapiens (human) ]

    Gene ID: 672, updated on 12-Apr-2024

    Summary

    Go to the top of the page Help
    Official Symbol
    BRCA1provided by HGNC
    Official Full Name
    BRCA1 DNA repair associatedprovided by HGNC
    Primary source
    HGNC:HGNC:1100
    See related
    Ensembl:ENSG00000012048 MIM:113705; AllianceGenome:HGNC:1100
    Gene type
    protein coding
    RefSeq status
    REVIEWED
    Organism
    Homo sapiens
    Lineage
    Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
    Also known as
    IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53
    Summary
    This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
    Expression
    Broad expression in testis (RPKM 5.2), lymph node (RPKM 3.3) and 23 other tissues See more
    Orthologs
    mouse all
    NEW
    Try the new Gene table
    Try the new Transcript table

    Genomic context

    Go to the top of the page Help
    See BRCA1 in Genome Data Viewer
    Location:
    17q21.31
    Exon count:
    31
    Annotation release Status Assembly Chr Location
    RS_2023_10 current GRCh38.p14 (GCF_000001405.40) 17 NC_000017.11 (43044295..43170327, complement)
    RS_2023_10 current T2T-CHM13v2.0 (GCF_009914755.1) 17 NC_060941.1 (43902857..44029084, complement)
    105.20220307 previous assembly GRCh37.p13 (GCF_000001405.25) 17 NC_000017.10 (41196312..41277381, complement)

    Chromosome 17 - NC_000017.11Genomic Context describing neighboring genes Neighboring gene ATAC-STARR-seq lymphoblastoid silent region 8550 Neighboring gene Sharpr-MPRA regulatory region 8675 Neighboring gene vesicle amine transport 1 Neighboring gene H3K27ac-H3K4me1 hESC enhancer GRCh37_chr17:41195058-41195600 Neighboring gene Rho family GTPase 2 Neighboring gene OCT4-NANOG hESC enhancer GRCh37_chr17:41214996-41215531 Neighboring gene ReSE screen-validated silencer GRCh37_chr17:41224055-41224260 Neighboring gene BRD4-independent group 4 enhancer GRCh37_chr17:41243136-41244335 Neighboring gene ribosomal protein L21 pseudogene 4 Neighboring gene BRCA1 intronic recombination region Neighboring gene BRCA1 intron 2 regulatory region Neighboring gene BRCA1 promoter region Neighboring gene OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr17:41298599-41299208 Neighboring gene neighbor of BRCA1 lncRNA 2 Neighboring gene uncharacterized LOC101929767 Neighboring gene high mobility group nucleosome binding domain 1 pseudogene 29 Neighboring gene BRCA1P1 intergenic recombination region Neighboring gene NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr17:41311429-41311959 Neighboring gene uncharacterized LOC124900391 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12236 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12237 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12238 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12239 Neighboring gene BRCA1 pseudogene 1 Neighboring gene NBR1 autophagy cargo receptor Neighboring gene Sharpr-MPRA regulatory region 10579 Neighboring gene transmembrane protein 106A

    Genomic regions, transcripts, and products

    Go to the top of the page Help

    Go to nucleotide: Graphics FASTA GenBank

    Expression

    Go to the top of the page Help
    • Project title: HPA RNA-seq normal tissues
    • Description: RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes
    • BioProject: PRJEB4337
    • Publication: PMID 24309898
    • Analysis date: Wed Apr 4 07:08:55 2018

    Bibliography

    Go to the top of the pageHelp

    Related articles in PubMed

    1. Hybrid-seq deciphers the complex transcriptional profile of the human BRCA1 DNA repair associated gene. Adamopoulos PG, et al. RNA Biol, 2023 Jan. PMID 37272060, Free PMC Article
    2. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays. Bassi N, et al. BMC Cancer, 2023 Apr 21. PMID 37085799, Free PMC Article
    3. Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians. Kerr SM, et al. Eur J Hum Genet, 2023 May. PMID 36927983, Free PMC Article
    4. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis. Nee K, et al. Nat Genet, 2023 Apr. PMID 36914836, Free PMC Article
    5. Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions. Hovland HN, et al. Genes (Basel), 2023 Jan 19. PMID 36833189, Free PMC Article

    See all (3360) citations in PubMed

    GeneRIFs: Gene References Into Functions

    What's a GeneRIF?
    1. Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.
      Title: Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.
    2. Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.
      Title: Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.
    3. Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
      Title: Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
    4. CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.
      Title: CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.
    5. Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.
      Title: Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.
    6. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
      Title: BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    7. Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
      Title: Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
    8. Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
      Title: Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
    9. Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
      Title: Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
    10. Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
      Title: Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
    Submit: New GeneRIF Correction See all GeneRIFs (2589)

    Phenotypes

    Go to the top of the page Help

    Find tests for this gene in the NIH Genetic Testing Registry (GTR)

    Review eQTL and phenotype association data in this region using PheGenI

    Professional guidelines

    Description
    Professional guideline
    ACMG 2013

    The ACMG recommends that laboratories performing clinical sequencing seek and report mutations in BRCA1 that are pathogenic or expected to be pathogenic.

    GuidelinePubMed

    Copy number response

    Description
    Copy number response
    Triplosensitivity

    No evidence available (Last evaluated 2021-09-23)

    ClinGen Genome Curation Page
    Haploinsufficency

    Sufficient evidence for dosage pathogenicity (Last evaluated 2021-09-23)

    ClinGen Genome Curation PagePubMed

    Variation

    Go to the top of the page Help

    See variants in ClinVar

    See studies and variants in dbVar

    See Variation Viewer (GRCh37.p13)

    See Variation Viewer (GRCh38)

    Genotypes

    HIV-1 interactions

    Go to the top of the page Help

    Replication interactions

    Interaction Pubs
    Knockdown of breast cancer 1, early onset (BRCA1) by siRNA inhibits HIV-1 replication in HeLa P4/R5 cells PubMed

    Protein interactions

    Protein Gene Interaction Pubs
    Tat tat HIV-1 Tat associates with BRCA1 in cells and the amino-acid 504-802 region of BRCA1 physically interacts with HIV-1 Tat PubMed
    tat BRCA1 enhances HIV-1 Tat-dependent transcription in cells, and BRCA1 phosphorylation at positions S1387, S1423, S1457, and S1524 is important for the enhancement of Tat-dependent transcription PubMed
    Vpr vpr HIV-1 Vpr stimulates the focus formation of Rad51 and BRCA1, which are involved in repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) PubMed
    vpr HIV-1 Vpr induces phosphorylation of BRCA1 at serine 1423 in an ATR-dependent manner PubMed
    vpr HIV-1 Vpr expression in HeLa cells induces formation of nuclear foci containing H2AFX and BRCA1 PubMed

    Go to the HIV-1, Human Interaction Database

    Pathways from PubChem

    Go to the top of the page

    Interactions

    Go to the top of the page Help
    Products Interactant Other Gene Complex Source Pubs Description

    General gene information

    Go to the top of the page Help

    Markers

    Homology

    Gene Ontology Provided by GOA

    Function Evidence Code Pubs
    enables DNA binding TAS
    Traceable Author Statement
    more info
    		 PubMed 
    enables DNA-binding transcription activator activity IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables RNA binding IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables RNA polymerase binding IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables damaged DNA binding IEA
    Inferred from Electronic Annotation
    more info
    		  
    enables enzyme binding IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    enables identical protein binding IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    enables p53 binding IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables protein binding IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    enables transcription cis-regulatory region binding IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables transcription coactivator activity IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    enables tubulin binding NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    enables ubiquitin protein ligase binding IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    enables ubiquitin-protein transferase activity IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    enables ubiquitin-protein transferase activity IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    enables ubiquitin-protein transferase activity TAS
    Traceable Author Statement
    more info
    		  
    enables zinc ion binding IEA
    Inferred from Electronic Annotation
    more info
    		  
    Process Evidence Code Pubs
    involved_in DNA damage response NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in DNA repair NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in DNA strand resection involved in replication fork processing NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in cellular response to indole-3-methanol IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in cellular response to ionizing radiation IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in cellular response to tumor necrosis factor IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in centrosome cycle IEA
    Inferred from Electronic Annotation
    more info
    		  
    involved_in chordate embryonic development IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    involved_in chromosome segregation IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in double-strand break repair IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in double-strand break repair IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in double-strand break repair TAS
    Traceable Author Statement
    more info
    		  
    involved_in double-strand break repair via homologous recombination IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    involved_in double-strand break repair via homologous recombination IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in fatty acid biosynthetic process IEA
    Inferred from Electronic Annotation
    more info
    		  
    involved_in homologous recombination NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    acts_upstream_of_or_within intrinsic apoptotic signaling pathway in response to DNA damage IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in localization IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in mitotic G2 DNA damage checkpoint signaling IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    involved_in mitotic G2 DNA damage checkpoint signaling IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in mitotic G2/M transition checkpoint NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in negative regulation of DNA-templated transcription IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in negative regulation of cell cycle NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in negative regulation of cell growth IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in negative regulation of centriole replication NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in negative regulation of extrinsic apoptotic signaling pathway via death domain receptors IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in negative regulation of fatty acid biosynthetic process IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    acts_upstream_of_positive_effect negative regulation of gene expression via chromosomal CpG island methylation IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in negative regulation of intracellular estrogen receptor signaling pathway IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in negative regulation of reactive oxygen species metabolic process IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of DNA repair IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of DNA-templated transcription IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in positive regulation of DNA-templated transcription IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of angiogenesis IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of gene expression IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of transcription by RNA polymerase II IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    involved_in positive regulation of transcription by RNA polymerase II IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in positive regulation of transcription by RNA polymerase II IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in positive regulation of vascular endothelial growth factor production IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in postreplication repair IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in protein K6-linked ubiquitination IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in protein autoubiquitination IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in protein ubiquitination IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in random inactivation of X chromosome IEA
    Inferred from Electronic Annotation
    more info
    		  
    involved_in regulation of DNA damage checkpoint NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    involved_in regulation of DNA repair NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    acts_upstream_of regulation of cell cycle IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    involved_in regulation of transcription by RNA polymerase II IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in response to ionizing radiation IMP
    Inferred from Mutant Phenotype
    more info
    		 PubMed 
    involved_in sex-chromosome dosage compensation IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    Component Evidence Code Pubs
    part_of BRCA1-A complex IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    part_of BRCA1-A complex IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of BRCA1-A complex NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    part_of BRCA1-B complex IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    part_of BRCA1-BARD1 complex IBA
    Inferred from Biological aspect of Ancestor
    more info
    		  
    part_of BRCA1-BARD1 complex IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of BRCA1-BARD1 complex IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    part_of BRCA1-C complex IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    part_of DNA repair complex IPI
    Inferred from Physical Interaction
    more info
    		 PubMed 
    located_in XY body IEA
    Inferred from Electronic Annotation
    more info
    		  
    located_in chromosome ISS
    Inferred from Sequence or Structural Similarity
    more info
    		  
    located_in cytoplasm IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of gamma-tubulin ring complex NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    is_active_in intracellular non-membrane-bounded organelle IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    located_in lateral element IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    located_in male germ cell nucleus IEA
    Inferred from Electronic Annotation
    more info
    		  
    located_in nuclear body IDA
    Inferred from Direct Assay
    more info
    		  
    part_of nuclear ubiquitin ligase complex IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    located_in nucleoplasm IDA
    Inferred from Direct Assay
    more info
    		  
    located_in nucleoplasm TAS
    Traceable Author Statement
    more info
    		  
    located_in nucleus IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    located_in nucleus NAS
    Non-traceable Author Statement
    more info
    		 PubMed 
    located_in plasma membrane IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of protein-containing complex IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of ribonucleoprotein complex IDA
    Inferred from Direct Assay
    more info
    		 PubMed 
    part_of ubiquitin ligase complex NAS
    Non-traceable Author Statement
    more info
    		 PubMed 

    General protein information

    Go to the top of the page Help
    Preferred Names
    breast cancer type 1 susceptibility protein
    Names
    BRCA1/BRCA2-containing complex, subunit 1
    Fanconi anemia, complementation group S
    RING finger protein 53
    breast and ovarian cancer susceptibility protein 1
    breast cancer 1, early onset
    early onset breast cancer 1
    protein phosphatase 1, regulatory subunit 53
    NP_001394500.1
    NP_001394510.1
    NP_001394511.1
    NP_001394512.1
    NP_001394514.1
    NP_001394516.1
    NP_001394519.1
    NP_001394520.1
    NP_001394522.1
    NP_001394523.1
    NP_001394525.1
    NP_001394526.1
    NP_001394527.1
    NP_001394531.1
    NP_001394532.1
    NP_001394534.1
    NP_001394539.1
    NP_001394540.1
    NP_001394541.1
    NP_001394542.1
    NP_001394543.1
    NP_001394544.1
    NP_001394545.1
    NP_001394546.1
    NP_001394547.1
    NP_001394548.1
    NP_001394549.1
    NP_001394550.1
    NP_001394551.1
    NP_001394552.1
    NP_001394553.1
    NP_001394554.1
    NP_001394555.1
    NP_001394556.1
    NP_001394557.1
    NP_001394558.1
    NP_001394559.1
    NP_001394560.1
    NP_001394561.1
    NP_001394562.1
    NP_001394563.1
    NP_001394564.1
    NP_001394565.1
    NP_001394566.1
    NP_001394567.1
    NP_001394568.1
    NP_001394569.1
    NP_001394570.1
    NP_001394571.1
    NP_001394573.1
    NP_001394574.1
    NP_001394575.1
    NP_001394576.1
    NP_001394577.1
    NP_001394578.1
    NP_001394581.1
    NP_001394582.1
    NP_001394583.1
    NP_001394584.1
    NP_001394585.1
    NP_001394586.1
    NP_001394587.1
    NP_001394588.1
    NP_001394589.1
    NP_001394590.1
    NP_001394591.1
    NP_001394592.1
    NP_001394593.1
    NP_001394594.1
    NP_001394595.1
    NP_001394596.1
    NP_001394597.1
    NP_001394598.1
    NP_001394599.1
    NP_001394600.1
    NP_001394601.1
    NP_001394602.1
    NP_001394603.1
    NP_001394604.1
    NP_001394605.1
    NP_001394606.1
    NP_001394607.1
    NP_001394608.1
    NP_001394609.1
    NP_001394610.1
    NP_001394611.1
    NP_001394612.1
    NP_001394613.1
    NP_001394614.1
    NP_001394615.1
    NP_001394616.1
    NP_001394617.1
    NP_001394618.1
    NP_001394619.1
    NP_001394620.1
    NP_001394621.1
    NP_001394623.1
    NP_001394624.1
    NP_001394625.1
    NP_001394626.1
    NP_001394627.1
    NP_001394653.1
    NP_001394654.1
    NP_001394655.1
    NP_001394656.1
    NP_001394657.1
    NP_001394658.1
    NP_001394659.1
    NP_001394660.1
    NP_001394661.1
    NP_001394662.1
    NP_001394663.1
    NP_001394664.1
    NP_001394665.1
    NP_001394666.1
    NP_001394667.1
    NP_001394668.1
    NP_001394669.1
    NP_001394670.1
    NP_001394671.1
    NP_001394672.1
    NP_001394673.1
    NP_001394674.1
    NP_001394675.1
    NP_001394676.1
    NP_001394677.1
    NP_001394678.1
    NP_001394679.1
    NP_001394680.1
    NP_001394681.1
    NP_001394767.1
    NP_001394768.1
    NP_001394770.1
    NP_001394771.1
    NP_001394772.1
    NP_001394773.1
    NP_001394774.1
    NP_001394775.1
    NP_001394776.1
    NP_001394777.1
    NP_001394778.1
    NP_001394779.1
    NP_001394780.1
    NP_001394781.1
    NP_001394782.1
    NP_001394783.1
    NP_001394787.1
    NP_001394788.1
    NP_001394789.1
    NP_001394790.1
    NP_001394791.1
    NP_001394792.1
    NP_001394803.1
    NP_001394804.1
    NP_001394808.1
    NP_001394810.1
    NP_001394811.1
    NP_001394813.1
    NP_001394814.1
    NP_001394815.1
    NP_001394816.1
    NP_001394818.1
    NP_001394823.1
    NP_001394824.1
    NP_001394825.1
    NP_001394826.1
    NP_001394827.1
    NP_001394828.1
    NP_001394829.1
    NP_001394831.1
    NP_001394833.1
    NP_001394835.1
    NP_001394836.1
    NP_001394837.1
    NP_001394838.1
    NP_001394839.1
    NP_001394844.1
    NP_001394845.1
    NP_001394846.1
    NP_001394847.1
    NP_001394848.1
    NP_001394849.1
    NP_001394850.1
    NP_001394851.1
    NP_001394852.1
    NP_001394853.1
    NP_001394854.1
    NP_001394855.1
    NP_001394856.1
    NP_001394857.1
    NP_001394858.1
    NP_001394859.1
    NP_001394860.1
    NP_001394861.1
    NP_001394862.1
    NP_001394863.1
    NP_001394864.1
    NP_001394865.1
    NP_001394866.1
    NP_001394867.1
    NP_001394868.1
    NP_001394869.1
    NP_001394870.1
    NP_001394871.1
    NP_001394872.1
    NP_001394873.1
    NP_001394874.1
    NP_001394875.1
    NP_001394876.1
    NP_001394877.1
    NP_001394878.1
    NP_001394879.1
    NP_001394880.1
    NP_001394881.1
    NP_001394882.1
    NP_001394883.1
    NP_001394884.1
    NP_001394885.1
    NP_001394886.1
    NP_001394887.1
    NP_001394888.1
    NP_001394889.1
    NP_001394891.1
    NP_001394892.1
    NP_001394893.1
    NP_001394894.1
    NP_001394895.1
    NP_001394896.1
    NP_001394897.1
    NP_001394898.1
    NP_001394899.1
    NP_001394900.1
    NP_001394901.1
    NP_001394902.1
    NP_001394903.1
    NP_001394904.1
    NP_001394905.1
    NP_001394906.1
    NP_001394907.1
    NP_001394908.1
    NP_001394909.1
    NP_001394910.1
    NP_001394911.1
    NP_001394912.1
    NP_001394913.1
    NP_001394914.1
    NP_001394915.1
    NP_001394919.1
    NP_001394920.1
    NP_001394921.1
    NP_001394922.1
    NP_001395321.1
    NP_001395325.1
    NP_001395326.1
    NP_001395327.1
    NP_001395328.1
    NP_001395329.1
    NP_001395330.1
    NP_001395331.1
    NP_001395332.1
    NP_001395333.1
    NP_001395335.1
    NP_001395336.1
    NP_001395337.1
    NP_001395338.1
    NP_001395339.1
    NP_001395340.1
    NP_001395341.1
    NP_001395342.1
    NP_001395343.1
    NP_001395344.1
    NP_001395345.1
    NP_001395347.1
    NP_001395348.1
    NP_001395349.1
    NP_001395350.1
    NP_001395351.1
    NP_001395352.1
    NP_001395353.1
    NP_001395354.1
    NP_001395355.1
    NP_001395356.1
    NP_001395357.1
    NP_001395358.1
    NP_001395359.1
    NP_001395360.1
    NP_001395361.1
    NP_001395362.1
    NP_001395363.1
    NP_001395364.1
    NP_001395365.1
    NP_001395366.1
    NP_001395367.1
    NP_001395368.1
    NP_001395369.1
    NP_001395370.1
    NP_001395371.1
    NP_001395372.1
    NP_001395373.1
    NP_001395374.1
    NP_001395375.1
    NP_001395376.1
    NP_001395377.1
    NP_001395379.1
    NP_001395380.1
    NP_001395381.1
    NP_001395382.1
    NP_001395383.1
    NP_001395384.1
    NP_001395385.1
    NP_001395386.1
    NP_001395387.1
    NP_001395388.1
    NP_001395389.1
    NP_001395390.1
    NP_001395391.1
    NP_001395392.1
    NP_001395393.1
    NP_001395394.1
    NP_001395395.1
    NP_001395396.1
    NP_001395397.1
    NP_001395398.1
    NP_001395399.1
    NP_001395401.1
    NP_001395402.1
    NP_001395403.1
    NP_001395404.1
    NP_001395405.1
    NP_001395407.1
    NP_001395408.1
    NP_001395409.1
    NP_001395410.1
    NP_001395411.1
    NP_001395412.1
    NP_001395413.1
    NP_001395414.1
    NP_001395418.1
    NP_001395419.1
    NP_001395420.1
    NP_001395421.1
    NP_001395422.1
    NP_001395423.1
    NP_001395424.1
    NP_001395425.1
    NP_001395426.1
    NP_001395427.1
    NP_001395428.1
    NP_001395429.1
    NP_001395430.1
    NP_001395431.1
    NP_001395432.1
    NP_001395433.1
    NP_001395434.1
    NP_001395435.1
    NP_001395436.1
    NP_001395437.1
    NP_001395438.1
    NP_001395439.1
    NP_001395440.1
    NP_001395441.1
    NP_001395442.1
    NP_001395443.1
    NP_009225.1
    NP_009228.2
    NP_009229.2
    NP_009230.2
    NP_009231.2

    NCBI Reference Sequences (RefSeq)

    Go to the top of the page Help

    NEW Try the new Transcript table

    RefSeqs maintained independently of Annotated Genomes

    These reference sequences exist independently of genome builds. Explain

    These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

    Genomic

    1. NG_005905.2 RefSeqGene

      Range
      92501..173689
      Download
      GenBank, FASTA, Sequence Viewer (Graphics), LRG_292

    mRNA and Protein(s)

    1. NM_001407571.1 → NP_001394500.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    2. NM_001407581.1 → NP_001394510.1  breast cancer type 1 susceptibility protein isoform 7

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y7V5
      Related
      ENSP00000496570.2, ENST00000644379.2

    3. NM_001407582.1 → NP_001394511.1  breast cancer type 1 susceptibility protein isoform 7

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y7V5

    4. NM_001407583.1 → NP_001394512.1  breast cancer type 1 susceptibility protein isoform 2

      Status: REVIEWED

      Source sequence(s)
      AC135721

    5. NM_001407585.1 → NP_001394514.1  breast cancer type 1 susceptibility protein isoform 2

      Status: REVIEWED

      Source sequence(s)
      AC135721

    6. NM_001407587.1 → NP_001394516.1  breast cancer type 1 susceptibility protein isoform 8

      Status: REVIEWED

      Source sequence(s)
      AC135721

    7. NM_001407590.1 → NP_001394519.1  breast cancer type 1 susceptibility protein isoform 9

      Status: REVIEWED

      Source sequence(s)
      AC135721

    8. NM_001407591.1 → NP_001394520.1  breast cancer type 1 susceptibility protein isoform 9

      Status: REVIEWED

      Source sequence(s)
      AC135721

    9. NM_001407593.1 → NP_001394522.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

    10. NM_001407594.1 → NP_001394523.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
      Related
      ENSP00000478114.2, ENST00000618469.2

    11. NM_001407596.1 → NP_001394525.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

    12. NM_001407597.1 → NP_001394526.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
      Related
      ENSP00000419274.2, ENST00000470026.6

    13. NM_001407598.1 → NP_001394527.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
      Related
      ENSP00000419103.2, ENST00000494123.6

    14. NM_001407602.1 → NP_001394531.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

    15. NM_001407603.1 → NP_001394532.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

    16. NM_001407605.1 → NP_001394534.1  breast cancer type 1 susceptibility protein isoform 1

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

    17. NM_001407610.1 → NP_001394539.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    18. NM_001407611.1 → NP_001394540.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    19. NM_001407612.1 → NP_001394541.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    20. NM_001407613.1 → NP_001394542.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    21. NM_001407614.1 → NP_001394543.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    22. NM_001407615.1 → NP_001394544.1  breast cancer type 1 susceptibility protein isoform 10

      Status: REVIEWED

      Source sequence(s)
      AC135721

    23. NM_001407616.1 → NP_001394545.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850
      Related
      ENSP00000417241.2, ENST00000461574.2

    24. NM_001407617.1 → NP_001394546.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    25. NM_001407618.1 → NP_001394547.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    26. NM_001407619.1 → NP_001394548.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    27. NM_001407620.1 → NP_001394549.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    28. NM_001407621.1 → NP_001394550.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    29. NM_001407622.1 → NP_001394551.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    30. NM_001407623.1 → NP_001394552.1  breast cancer type 1 susceptibility protein isoform 11

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y850

    31. NM_001407624.1 → NP_001394553.1  breast cancer type 1 susceptibility protein isoform 12

      Status: REVIEWED

      Source sequence(s)
      AC135721

    32. NM_001407625.1 → NP_001394554.1  breast cancer type 1 susceptibility protein isoform 12

      Status: REVIEWED

      Source sequence(s)
      AC135721

    33. NM_001407626.1 → NP_001394555.1  breast cancer type 1 susceptibility protein isoform 12

      Status: REVIEWED

      Source sequence(s)
      AC135721

    34. NM_001407627.1 → NP_001394556.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4

    35. NM_001407628.1 → NP_001394557.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4
      Related
      ENSP00000417554.2, ENST00000476777.6

    36. NM_001407629.1 → NP_001394558.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4

    37. NM_001407630.1 → NP_001394559.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4

    38. NM_001407631.1 → NP_001394560.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4

    39. NM_001407632.1 → NP_001394561.1  breast cancer type 1 susceptibility protein isoform 13

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EQW4

    40. NM_001407633.1 → NP_001394562.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    41. NM_001407634.1 → NP_001394563.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    42. NM_001407635.1 → NP_001394564.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    43. NM_001407636.1 → NP_001394565.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    44. NM_001407637.1 → NP_001394566.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    45. NM_001407638.1 → NP_001394567.1  breast cancer type 1 susceptibility protein isoform 14

      Status: REVIEWED

      Source sequence(s)
      AC135721

    46. NM_001407639.1 → NP_001394568.1  breast cancer type 1 susceptibility protein isoform 15

      Status: REVIEWED

      Source sequence(s)
      AC135721

    47. NM_001407640.1 → NP_001394569.1  breast cancer type 1 susceptibility protein isoform 15

      Status: REVIEWED

      Source sequence(s)
      AC135721

    48. NM_001407641.1 → NP_001394570.1  breast cancer type 1 susceptibility protein isoform 15

      Status: REVIEWED

      Source sequence(s)
      AC135721

    49. NM_001407642.1 → NP_001394571.1  breast cancer type 1 susceptibility protein isoform 15

      Status: REVIEWED

      Source sequence(s)
      AC135721

    50. NM_001407644.1 → NP_001394573.1  breast cancer type 1 susceptibility protein isoform 16

      Status: REVIEWED

      Source sequence(s)
      AC135721

    51. NM_001407645.1 → NP_001394574.1  breast cancer type 1 susceptibility protein isoform 16

      Status: REVIEWED

      Source sequence(s)
      AC135721

    52. NM_001407646.1 → NP_001394575.1  breast cancer type 1 susceptibility protein isoform 17

      Status: REVIEWED

      Source sequence(s)
      AC135721

    53. NM_001407647.1 → NP_001394576.1  breast cancer type 1 susceptibility protein isoform 18

      Status: REVIEWED

      Source sequence(s)
      AC135721

    54. NM_001407648.1 → NP_001394577.1  breast cancer type 1 susceptibility protein isoform 19

      Status: REVIEWED

      Source sequence(s)
      AC135721

    55. NM_001407649.1 → NP_001394578.1  breast cancer type 1 susceptibility protein isoform 20

      Status: REVIEWED

      Source sequence(s)
      AC135721

    56. NM_001407652.1 → NP_001394581.1  breast cancer type 1 susceptibility protein isoform 21

      Status: REVIEWED

      Source sequence(s)
      AC135721

    57. NM_001407653.1 → NP_001394582.1  breast cancer type 1 susceptibility protein isoform 22

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7ENB7, E9PH68
      Related
      ENSP00000419988.2, ENST00000477152.6

    58. NM_001407654.1 → NP_001394583.1  breast cancer type 1 susceptibility protein isoform 22

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7ENB7, E9PH68

    59. NM_001407655.1 → NP_001394584.1  breast cancer type 1 susceptibility protein isoform 22

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7ENB7, E9PH68

    60. NM_001407656.1 → NP_001394585.1  breast cancer type 1 susceptibility protein isoform 23

      Status: REVIEWED

      Source sequence(s)
      AC135721

    61. NM_001407657.1 → NP_001394586.1  breast cancer type 1 susceptibility protein isoform 24

      Status: REVIEWED

      Source sequence(s)
      AC135721

    62. NM_001407658.1 → NP_001394587.1  breast cancer type 1 susceptibility protein isoform 24

      Status: REVIEWED

      Source sequence(s)
      AC135721

    63. NM_001407659.1 → NP_001394588.1  breast cancer type 1 susceptibility protein isoform 25

      Status: REVIEWED

      Source sequence(s)
      AC135721

    64. NM_001407660.1 → NP_001394589.1  breast cancer type 1 susceptibility protein isoform 25

      Status: REVIEWED

      Source sequence(s)
      AC135721

    65. NM_001407661.1 → NP_001394590.1  breast cancer type 1 susceptibility protein isoform 26

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQD3

    66. NM_001407662.1 → NP_001394591.1  breast cancer type 1 susceptibility protein isoform 26

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQD3

    67. NM_001407663.1 → NP_001394592.1  breast cancer type 1 susceptibility protein isoform 93

      Status: REVIEWED

      Source sequence(s)
      AC135721

    68. NM_001407664.1 → NP_001394593.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9

    69. NM_001407665.1 → NP_001394594.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9

    70. NM_001407666.1 → NP_001394595.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9

    71. NM_001407667.1 → NP_001394596.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9
      Related
      ENSP00000489431.2, ENST00000634433.2

    72. NM_001407668.1 → NP_001394597.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9

    73. NM_001407669.1 → NP_001394598.1  breast cancer type 1 susceptibility protein isoform 27

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A0U1RRA9

    74. NM_001407670.1 → NP_001394599.1  breast cancer type 1 susceptibility protein isoform 28

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y8D8
      Related
      ENSP00000420201.2, ENST00000473961.6

    75. NM_001407671.1 → NP_001394600.1  breast cancer type 1 susceptibility protein isoform 28

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y8D8

    76. NM_001407672.1 → NP_001394601.1  breast cancer type 1 susceptibility protein isoform 28

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y8D8

    77. NM_001407673.1 → NP_001394602.1  breast cancer type 1 susceptibility protein isoform 28

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      H0Y8D8

    78. NM_001407674.1 → NP_001394603.1  breast cancer type 1 susceptibility protein isoform 29

      Status: REVIEWED

      Source sequence(s)
      AC135721

    79. NM_001407675.1 → NP_001394604.1  breast cancer type 1 susceptibility protein isoform 29

      Status: REVIEWED

      Source sequence(s)
      AC135721

    80. NM_001407676.1 → NP_001394605.1  breast cancer type 1 susceptibility protein isoform 29

      Status: REVIEWED

      Source sequence(s)
      AC135721

    81. NM_001407677.1 → NP_001394606.1  breast cancer type 1 susceptibility protein isoform 30

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQJ6

    82. NM_001407678.1 → NP_001394607.1  breast cancer type 1 susceptibility protein isoform 30

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQJ6

    83. NM_001407679.1 → NP_001394608.1  breast cancer type 1 susceptibility protein isoform 30

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQJ6

    84. NM_001407680.1 → NP_001394609.1  breast cancer type 1 susceptibility protein isoform 30

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQJ6

    85. NM_001407681.1 → NP_001394610.1  breast cancer type 1 susceptibility protein isoform 31

      Status: REVIEWED

      Source sequence(s)
      AC135721

    86. NM_001407682.1 → NP_001394611.1  breast cancer type 1 susceptibility protein isoform 31

      Status: REVIEWED

      Source sequence(s)
      AC135721

    87. NM_001407683.1 → NP_001394612.1  breast cancer type 1 susceptibility protein isoform 31

      Status: REVIEWED

      Source sequence(s)
      AC135721

    88. NM_001407684.1 → NP_001394613.1  breast cancer type 1 susceptibility protein isoform 32

      Status: REVIEWED

      Source sequence(s)
      AC135721

    89. NM_001407685.1 → NP_001394614.1  breast cancer type 1 susceptibility protein isoform 33

      Status: REVIEWED

      Source sequence(s)
      AC135721

    90. NM_001407686.1 → NP_001394615.1  breast cancer type 1 susceptibility protein isoform 33

      Status: REVIEWED

      Source sequence(s)
      AC135721

    91. NM_001407687.1 → NP_001394616.1  breast cancer type 1 susceptibility protein isoform 33

      Status: REVIEWED

      Source sequence(s)
      AC135721

    92. NM_001407688.1 → NP_001394617.1  breast cancer type 1 susceptibility protein isoform 34

      Status: REVIEWED

      Source sequence(s)
      AC135721

    93. NM_001407689.1 → NP_001394618.1  breast cancer type 1 susceptibility protein isoform 34

      Status: REVIEWED

      Source sequence(s)
      AC135721

    94. NM_001407690.1 → NP_001394619.1  breast cancer type 1 susceptibility protein isoform 35

      Status: REVIEWED

      Source sequence(s)
      AC135721

    95. NM_001407691.1 → NP_001394620.1  breast cancer type 1 susceptibility protein isoform 35

      Status: REVIEWED

      Source sequence(s)
      AC135721

    96. NM_001407692.1 → NP_001394621.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    97. NM_001407694.1 → NP_001394623.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    98. NM_001407695.1 → NP_001394624.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    99. NM_001407696.1 → NP_001394625.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    100. NM_001407697.1 → NP_001394626.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    101. NM_001407698.1 → NP_001394627.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    102. NM_001407724.1 → NP_001394653.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    103. NM_001407725.1 → NP_001394654.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    104. NM_001407726.1 → NP_001394655.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    105. NM_001407727.1 → NP_001394656.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    106. NM_001407728.1 → NP_001394657.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    107. NM_001407729.1 → NP_001394658.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    108. NM_001407730.1 → NP_001394659.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3
      Related
      ENSP00000498906.2, ENST00000652672.2

    109. NM_001407731.1 → NP_001394660.1  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK3

    110. NM_001407732.1 → NP_001394661.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    111. NM_001407733.1 → NP_001394662.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    112. NM_001407734.1 → NP_001394663.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    113. NM_001407735.1 → NP_001394664.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    114. NM_001407736.1 → NP_001394665.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    115. NM_001407737.1 → NP_001394666.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    116. NM_001407738.1 → NP_001394667.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    117. NM_001407739.1 → NP_001394668.1  breast cancer type 1 susceptibility protein isoform 36

      Status: REVIEWED

      Source sequence(s)
      AC135721

    118. NM_001407740.1 → NP_001394669.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    119. NM_001407741.1 → NP_001394670.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    120. NM_001407742.1 → NP_001394671.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    121. NM_001407743.1 → NP_001394672.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    122. NM_001407744.1 → NP_001394673.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    123. NM_001407745.1 → NP_001394674.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    124. NM_001407746.1 → NP_001394675.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    125. NM_001407747.1 → NP_001394676.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    126. NM_001407748.1 → NP_001394677.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    127. NM_001407749.1 → NP_001394678.1  breast cancer type 1 susceptibility protein isoform 37

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQK7

    128. NM_001407750.1 → NP_001394679.1  breast cancer type 1 susceptibility protein isoform 38

      Status: REVIEWED

      Source sequence(s)
      AC135721

    129. NM_001407751.1 → NP_001394680.1  breast cancer type 1 susceptibility protein isoform 38

      Status: REVIEWED

      Source sequence(s)
      AC135721

    130. NM_001407752.1 → NP_001394681.1  breast cancer type 1 susceptibility protein isoform 38

      Status: REVIEWED

      Source sequence(s)
      AC135721

    131. NM_001407838.1 → NP_001394767.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    132. NM_001407839.1 → NP_001394768.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    133. NM_001407841.1 → NP_001394770.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    134. NM_001407842.1 → NP_001394771.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    135. NM_001407843.1 → NP_001394772.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    136. NM_001407844.1 → NP_001394773.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    137. NM_001407845.1 → NP_001394774.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    138. NM_001407846.1 → NP_001394775.1  breast cancer type 1 susceptibility protein isoform 39

      Status: REVIEWED

      Source sequence(s)
      AC135721

    139. NM_001407847.1 → NP_001394776.1  breast cancer type 1 susceptibility protein isoform 40

      Status: REVIEWED

      Source sequence(s)
      AC135721

    140. NM_001407848.1 → NP_001394777.1  breast cancer type 1 susceptibility protein isoform 40

      Status: REVIEWED

      Source sequence(s)
      AC135721

    141. NM_001407849.1 → NP_001394778.1  breast cancer type 1 susceptibility protein isoform 40

      Status: REVIEWED

      Source sequence(s)
      AC135721

    142. NM_001407850.1 → NP_001394779.1  breast cancer type 1 susceptibility protein isoform 41

      Status: REVIEWED

      Source sequence(s)
      AC135721

    143. NM_001407851.1 → NP_001394780.1  breast cancer type 1 susceptibility protein isoform 41

      Status: REVIEWED

      Source sequence(s)
      AC135721

    144. NM_001407852.1 → NP_001394781.1  breast cancer type 1 susceptibility protein isoform 41

      Status: REVIEWED

      Source sequence(s)
      AC135721

    145. NM_001407853.1 → NP_001394782.1  breast cancer type 1 susceptibility protein isoform 42

      Status: REVIEWED

      Source sequence(s)
      AC135721

    146. NM_001407854.1 → NP_001394783.1  breast cancer type 1 susceptibility protein isoform 43

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QPY6

    147. NM_001407858.1 → NP_001394787.1  breast cancer type 1 susceptibility protein isoform 44

      Status: REVIEWED

      Source sequence(s)
      AC135721

    148. NM_001407859.1 → NP_001394788.1  breast cancer type 1 susceptibility protein isoform 44

      Status: REVIEWED

      Source sequence(s)
      AC135721

    149. NM_001407860.1 → NP_001394789.1  breast cancer type 1 susceptibility protein isoform 45

      Status: REVIEWED

      Source sequence(s)
      AC135721

    150. NM_001407861.1 → NP_001394790.1  breast cancer type 1 susceptibility protein isoform 46

      Status: REVIEWED

      Source sequence(s)
      AC135721

    151. NM_001407862.1 → NP_001394791.1  breast cancer type 1 susceptibility protein isoform 47

      Status: REVIEWED

      Source sequence(s)
      AC135721

    152. NM_001407863.1 → NP_001394792.1  breast cancer type 1 susceptibility protein isoform 48

      Status: REVIEWED

      Source sequence(s)
      AC135721

    153. NM_001407874.1 → NP_001394803.1  breast cancer type 1 susceptibility protein isoform 49

      Status: REVIEWED

      Source sequence(s)
      AC135721

    154. NM_001407875.1 → NP_001394804.1  breast cancer type 1 susceptibility protein isoform 49

      Status: REVIEWED

      Source sequence(s)
      AC135721

    155. NM_001407879.1 → NP_001394808.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    156. NM_001407881.1 → NP_001394810.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    157. NM_001407882.1 → NP_001394811.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    158. NM_001407884.1 → NP_001394813.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    159. NM_001407885.1 → NP_001394814.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    160. NM_001407886.1 → NP_001394815.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    161. NM_001407887.1 → NP_001394816.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    162. NM_001407889.1 → NP_001394818.1  breast cancer type 1 susceptibility protein isoform 50

      Status: REVIEWED

      Source sequence(s)
      AC135721

    163. NM_001407894.1 → NP_001394823.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    164. NM_001407895.1 → NP_001394824.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    165. NM_001407896.1 → NP_001394825.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    166. NM_001407897.1 → NP_001394826.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    167. NM_001407898.1 → NP_001394827.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    168. NM_001407899.1 → NP_001394828.1  breast cancer type 1 susceptibility protein isoform 6

      Status: REVIEWED

      Source sequence(s)
      AC135721

    169. NM_001407900.1 → NP_001394829.1  breast cancer type 1 susceptibility protein isoform 52

      Status: REVIEWED

      Source sequence(s)
      AC135721

    170. NM_001407902.1 → NP_001394831.1  breast cancer type 1 susceptibility protein isoform 52

      Status: REVIEWED

      Source sequence(s)
      AC135721

    171. NM_001407904.1 → NP_001394833.1  breast cancer type 1 susceptibility protein isoform 52

      Status: REVIEWED

      Source sequence(s)
      AC135721

    172. NM_001407906.1 → NP_001394835.1  breast cancer type 1 susceptibility protein isoform 52

      Status: REVIEWED

      Source sequence(s)
      AC135721

    173. NM_001407907.1 → NP_001394836.1  breast cancer type 1 susceptibility protein isoform 53

      Status: REVIEWED

      Source sequence(s)
      AC135721

    174. NM_001407908.1 → NP_001394837.1  breast cancer type 1 susceptibility protein isoform 53

      Status: REVIEWED

      Source sequence(s)
      AC135721

    175. NM_001407909.1 → NP_001394838.1  breast cancer type 1 susceptibility protein isoform 53

      Status: REVIEWED

      Source sequence(s)
      AC135721

    176. NM_001407910.1 → NP_001394839.1  breast cancer type 1 susceptibility protein isoform 53

      Status: REVIEWED

      Source sequence(s)
      AC135721

    177. NM_001407915.1 → NP_001394844.1  breast cancer type 1 susceptibility protein isoform 54

      Status: REVIEWED

      Source sequence(s)
      AC135721

    178. NM_001407916.1 → NP_001394845.1  breast cancer type 1 susceptibility protein isoform 55

      Status: REVIEWED

      Source sequence(s)
      AC135721

    179. NM_001407917.1 → NP_001394846.1  breast cancer type 1 susceptibility protein isoform 55

      Status: REVIEWED

      Source sequence(s)
      AC135721

    180. NM_001407918.1 → NP_001394847.1  breast cancer type 1 susceptibility protein isoform 55

      Status: REVIEWED

      Source sequence(s)
      AC135721

    181. NM_001407919.1 → NP_001394848.1  breast cancer type 1 susceptibility protein isoform 56

      Status: REVIEWED

      Source sequence(s)
      AC135721

    182. NM_001407920.1 → NP_001394849.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    183. NM_001407921.1 → NP_001394850.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    184. NM_001407922.1 → NP_001394851.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    185. NM_001407923.1 → NP_001394852.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    186. NM_001407924.1 → NP_001394853.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    187. NM_001407925.1 → NP_001394854.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    188. NM_001407926.1 → NP_001394855.1  breast cancer type 1 susceptibility protein isoform 57

      Status: REVIEWED

      Source sequence(s)
      AC135721

    189. NM_001407927.1 → NP_001394856.1  breast cancer type 1 susceptibility protein isoform 58

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VR53

    190. NM_001407928.1 → NP_001394857.1  breast cancer type 1 susceptibility protein isoform 58

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VR53

    191. NM_001407929.1 → NP_001394858.1  breast cancer type 1 susceptibility protein isoform 58

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VR53

    192. NM_001407930.1 → NP_001394859.1  breast cancer type 1 susceptibility protein isoform 59

      Status: REVIEWED

      Source sequence(s)
      AC135721

    193. NM_001407931.1 → NP_001394860.1  breast cancer type 1 susceptibility protein isoform 59

      Status: REVIEWED

      Source sequence(s)
      AC135721

    194. NM_001407932.1 → NP_001394861.1  breast cancer type 1 susceptibility protein isoform 59

      Status: REVIEWED

      Source sequence(s)
      AC135721

    195. NM_001407933.1 → NP_001394862.1  breast cancer type 1 susceptibility protein isoform 60

      Status: REVIEWED

      Source sequence(s)
      AC135721

    196. NM_001407934.1 → NP_001394863.1  breast cancer type 1 susceptibility protein isoform 61

      Status: REVIEWED

      Source sequence(s)
      AC135721

    197. NM_001407935.1 → NP_001394864.1  breast cancer type 1 susceptibility protein isoform 62

      Status: REVIEWED

      Source sequence(s)
      AC135721

    198. NM_001407936.1 → NP_001394865.1  breast cancer type 1 susceptibility protein isoform 63

      Status: REVIEWED

      Source sequence(s)
      AC135721

    199. NM_001407937.1 → NP_001394866.1  breast cancer type 1 susceptibility protein isoform 64

      Status: REVIEWED

      Source sequence(s)
      AC135721

    200. NM_001407938.1 → NP_001394867.1  breast cancer type 1 susceptibility protein isoform 64

      Status: REVIEWED

      Source sequence(s)
      AC135721

    201. NM_001407939.1 → NP_001394868.1  breast cancer type 1 susceptibility protein isoform 65

      Status: REVIEWED

      Source sequence(s)
      AC135721

    202. NM_001407940.1 → NP_001394869.1  breast cancer type 1 susceptibility protein isoform 66

      Status: REVIEWED

      Source sequence(s)
      AC135721

    203. NM_001407941.1 → NP_001394870.1  breast cancer type 1 susceptibility protein isoform 67

      Status: REVIEWED

      Source sequence(s)
      AC135721

    204. NM_001407942.1 → NP_001394871.1  breast cancer type 1 susceptibility protein isoform 68

      Status: REVIEWED

      Source sequence(s)
      AC135721

    205. NM_001407943.1 → NP_001394872.1  breast cancer type 1 susceptibility protein isoform 69

      Status: REVIEWED

      Source sequence(s)
      AC135721

    206. NM_001407944.1 → NP_001394873.1  breast cancer type 1 susceptibility protein isoform 70

      Status: REVIEWED

      Source sequence(s)
      AC135721

    207. NM_001407945.1 → NP_001394874.1  breast cancer type 1 susceptibility protein isoform 70

      Status: REVIEWED

      Source sequence(s)
      AC135721

    208. NM_001407946.1 → NP_001394875.1  breast cancer type 1 susceptibility protein isoform 71

      Status: REVIEWED

      Source sequence(s)
      AC135721

    209. NM_001407947.1 → NP_001394876.1  breast cancer type 1 susceptibility protein isoform 71

      Status: REVIEWED

      Source sequence(s)
      AC135721

    210. NM_001407948.1 → NP_001394877.1  breast cancer type 1 susceptibility protein isoform 71

      Status: REVIEWED

      Source sequence(s)
      AC135721

    211. NM_001407949.1 → NP_001394878.1  breast cancer type 1 susceptibility protein isoform 71

      Status: REVIEWED

      Source sequence(s)
      AC135721

    212. NM_001407950.1 → NP_001394879.1  breast cancer type 1 susceptibility protein isoform 72

      Status: REVIEWED

      Source sequence(s)
      AC135721

    213. NM_001407951.1 → NP_001394880.1  breast cancer type 1 susceptibility protein isoform 72

      Status: REVIEWED

      Source sequence(s)
      AC135721

    214. NM_001407952.1 → NP_001394881.1  breast cancer type 1 susceptibility protein isoform 73

      Status: REVIEWED

      Source sequence(s)
      AC135721

    215. NM_001407953.1 → NP_001394882.1  breast cancer type 1 susceptibility protein isoform 73

      Status: REVIEWED

      Source sequence(s)
      AC135721

    216. NM_001407954.1 → NP_001394883.1  breast cancer type 1 susceptibility protein isoform 74

      Status: REVIEWED

      Source sequence(s)
      AC135721

    217. NM_001407955.1 → NP_001394884.1  breast cancer type 1 susceptibility protein isoform 74

      Status: REVIEWED

      Source sequence(s)
      AC135721

    218. NM_001407956.1 → NP_001394885.1  breast cancer type 1 susceptibility protein isoform 75

      Status: REVIEWED

      Source sequence(s)
      AC135721

    219. NM_001407957.1 → NP_001394886.1  breast cancer type 1 susceptibility protein isoform 76

      Status: REVIEWED

      Source sequence(s)
      AC135721

    220. NM_001407958.1 → NP_001394887.1  breast cancer type 1 susceptibility protein isoform 77

      Status: REVIEWED

      Source sequence(s)
      AC135721

    221. NM_001407959.1 → NP_001394888.1  breast cancer type 1 susceptibility protein isoform 78

      Status: REVIEWED

      Source sequence(s)
      AC135721

    222. NM_001407960.1 → NP_001394889.1  breast cancer type 1 susceptibility protein isoform 79

      Status: REVIEWED

      Source sequence(s)
      AC135721

    223. NM_001407962.1 → NP_001394891.1  breast cancer type 1 susceptibility protein isoform 80

      Status: REVIEWED

      Source sequence(s)
      AC135721

    224. NM_001407963.1 → NP_001394892.1  breast cancer type 1 susceptibility protein isoform 81

      Status: REVIEWED

      Source sequence(s)
      AC135721

    225. NM_001407964.1 → NP_001394893.1  breast cancer type 1 susceptibility protein isoform 82

      Status: REVIEWED

      Source sequence(s)
      AC135721

    226. NM_001407965.1 → NP_001394894.1  breast cancer type 1 susceptibility protein isoform 83

      Status: REVIEWED

      Source sequence(s)
      AC135721

    227. NM_001407966.1 → NP_001394895.1  breast cancer type 1 susceptibility protein isoform 84

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      C9IZW4
      Related
      ENSP00000418986.2, ENST00000497488.2

    228. NM_001407967.1 → NP_001394896.1  breast cancer type 1 susceptibility protein isoform 85

      Status: REVIEWED

      Source sequence(s)
      AC135721

    229. NM_001407968.1 → NP_001394897.1  breast cancer type 1 susceptibility protein isoform 86

      Status: REVIEWED

      Source sequence(s)
      AC135721

    230. NM_001407969.1 → NP_001394898.1  breast cancer type 1 susceptibility protein isoform 87

      Status: REVIEWED

      Source sequence(s)
      AC135721

    231. NM_001407970.1 → NP_001394899.1  breast cancer type 1 susceptibility protein isoform 88

      Status: REVIEWED

      Source sequence(s)
      AC135721

    232. NM_001407971.1 → NP_001394900.1  breast cancer type 1 susceptibility protein isoform 88

      Status: REVIEWED

      Source sequence(s)
      AC135721

    233. NM_001407972.1 → NP_001394901.1  breast cancer type 1 susceptibility protein isoform 89

      Status: REVIEWED

      Source sequence(s)
      AC135721

    234. NM_001407973.1 → NP_001394902.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    235. NM_001407974.1 → NP_001394903.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    236. NM_001407975.1 → NP_001394904.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    237. NM_001407976.1 → NP_001394905.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    238. NM_001407977.1 → NP_001394906.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    239. NM_001407978.1 → NP_001394907.1  breast cancer type 1 susceptibility protein isoform 90

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVE2

    240. NM_001407979.1 → NP_001394908.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    241. NM_001407980.1 → NP_001394909.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    242. NM_001407981.1 → NP_001394910.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    243. NM_001407982.1 → NP_001394911.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    244. NM_001407983.1 → NP_001394912.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    245. NM_001407984.1 → NP_001394913.1  breast cancer type 1 susceptibility protein isoform 92

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EUM2

    246. NM_001407985.1 → NP_001394914.1  breast cancer type 1 susceptibility protein isoform 92

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EUM2
      Related
      ENSP00000420412.2, ENST00000478531.6

    247. NM_001407986.1 → NP_001394915.1  breast cancer type 1 susceptibility protein isoform 92

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EUM2

    248. NM_001407990.1 → NP_001394919.1  breast cancer type 1 susceptibility protein isoform 91

      Status: REVIEWED

      Source sequence(s)
      AC135721

    249. NM_001407991.1 → NP_001394920.1  breast cancer type 1 susceptibility protein isoform 92

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EUM2

    250. NM_001407992.1 → NP_001394921.1  breast cancer type 1 susceptibility protein isoform 92

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      E7EUM2

    251. NM_001407993.1 → NP_001394922.1  breast cancer type 1 susceptibility protein isoform 4

      Status: REVIEWED

      Source sequence(s)
      AC135721
      Related
      ENSP00000420705.2, ENST00000491747.6

    252. NM_001408392.1 → NP_001395321.1  breast cancer type 1 susceptibility protein isoform 94

      Status: REVIEWED

      Source sequence(s)
      AC135721

    253. NM_001408396.1 → NP_001395325.1  breast cancer type 1 susceptibility protein isoform 94

      Status: REVIEWED

      Source sequence(s)
      AC135721

    254. NM_001408397.1 → NP_001395326.1  breast cancer type 1 susceptibility protein isoform 94

      Status: REVIEWED

      Source sequence(s)
      AC135721

    255. NM_001408398.1 → NP_001395327.1  breast cancer type 1 susceptibility protein isoform 94

      Status: REVIEWED

      Source sequence(s)
      AC135721

    256. NM_001408399.1 → NP_001395328.1  breast cancer type 1 susceptibility protein isoform 94

      Status: REVIEWED

      Source sequence(s)
      AC135721

    257. NM_001408400.1 → NP_001395329.1  breast cancer type 1 susceptibility protein isoform 95

      Status: REVIEWED

      Source sequence(s)
      AC135721

    258. NM_001408401.1 → NP_001395330.1  breast cancer type 1 susceptibility protein isoform 95

      Status: REVIEWED

      Source sequence(s)
      AC135721

    259. NM_001408402.1 → NP_001395331.1  breast cancer type 1 susceptibility protein isoform 95

      Status: REVIEWED

      Source sequence(s)
      AC135721

    260. NM_001408403.1 → NP_001395332.1  breast cancer type 1 susceptibility protein isoform 96

      Status: REVIEWED

      Source sequence(s)
      AC135721

    261. NM_001408404.1 → NP_001395333.1  breast cancer type 1 susceptibility protein isoform 96

      Status: REVIEWED

      Source sequence(s)
      AC135721

    262. NM_001408406.1 → NP_001395335.1  breast cancer type 1 susceptibility protein isoform 97

      Status: REVIEWED

      Source sequence(s)
      AC135721

    263. NM_001408407.1 → NP_001395336.1  breast cancer type 1 susceptibility protein isoform 98

      Status: REVIEWED

      Source sequence(s)
      AC135721

    264. NM_001408408.1 → NP_001395337.1  breast cancer type 1 susceptibility protein isoform 99

      Status: REVIEWED

      Source sequence(s)
      AC135721

    265. NM_001408409.1 → NP_001395338.1  breast cancer type 1 susceptibility protein isoform 100

      Status: REVIEWED

      Source sequence(s)
      AC135721

    266. NM_001408410.1 → NP_001395339.1  breast cancer type 1 susceptibility protein isoform 101

      Status: REVIEWED

      Source sequence(s)
      AC135721

    267. NM_001408411.1 → NP_001395340.1  breast cancer type 1 susceptibility protein isoform 102

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1VVD0

    268. NM_001408412.1 → NP_001395341.1  breast cancer type 1 susceptibility protein isoform 103

      Status: REVIEWED

      Source sequence(s)
      AC135721

    269. NM_001408413.1 → NP_001395342.1  breast cancer type 1 susceptibility protein isoform 104

      Status: REVIEWED

      Source sequence(s)
      AC135721

    270. NM_001408414.1 → NP_001395343.1  breast cancer type 1 susceptibility protein isoform 103

      Status: REVIEWED

      Source sequence(s)
      AC135721

    271. NM_001408415.1 → NP_001395344.1  breast cancer type 1 susceptibility protein isoform 103

      Status: REVIEWED

      Source sequence(s)
      AC135721

    272. NM_001408416.1 → NP_001395345.1  breast cancer type 1 susceptibility protein isoform 104

      Status: REVIEWED

      Source sequence(s)
      AC135721

    273. NM_001408418.1 → NP_001395347.1  breast cancer type 1 susceptibility protein isoform 105

      Status: REVIEWED

      Source sequence(s)
      AC135721

    274. NM_001408419.1 → NP_001395348.1  breast cancer type 1 susceptibility protein isoform 105

      Status: REVIEWED

      Source sequence(s)
      AC135721
      Related
      ENSP00000312236.5, ENST00000352993.7

    275. NM_001408420.1 → NP_001395349.1  breast cancer type 1 susceptibility protein isoform 105

      Status: REVIEWED

      Source sequence(s)
      AC135721

    276. NM_001408421.1 → NP_001395350.1  breast cancer type 1 susceptibility protein isoform 106

      Status: REVIEWED

      Source sequence(s)
      AC135721

    277. NM_001408422.1 → NP_001395351.1  breast cancer type 1 susceptibility protein isoform 107

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QPR4

    278. NM_001408423.1 → NP_001395352.1  breast cancer type 1 susceptibility protein isoform 107

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QPR4

    279. NM_001408424.1 → NP_001395353.1  breast cancer type 1 susceptibility protein isoform 106

      Status: REVIEWED

      Source sequence(s)
      AC135721

    280. NM_001408425.1 → NP_001395354.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    281. NM_001408426.1 → NP_001395355.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    282. NM_001408427.1 → NP_001395356.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    283. NM_001408428.1 → NP_001395357.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    284. NM_001408429.1 → NP_001395358.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    285. NM_001408430.1 → NP_001395359.1  breast cancer type 1 susceptibility protein isoform 108

      Status: REVIEWED

      Source sequence(s)
      AC135721

    286. NM_001408431.1 → NP_001395360.1  breast cancer type 1 susceptibility protein isoform 109

      Status: REVIEWED

      Source sequence(s)
      AC135721

    287. NM_001408432.1 → NP_001395361.1  breast cancer type 1 susceptibility protein isoform 110

      Status: REVIEWED

      Source sequence(s)
      AC135721

    288. NM_001408433.1 → NP_001395362.1  breast cancer type 1 susceptibility protein isoform 110

      Status: REVIEWED

      Source sequence(s)
      AC135721

    289. NM_001408434.1 → NP_001395363.1  breast cancer type 1 susceptibility protein isoform 110

      Status: REVIEWED

      Source sequence(s)
      AC135721

    290. NM_001408435.1 → NP_001395364.1  breast cancer type 1 susceptibility protein isoform 110

      Status: REVIEWED

      Source sequence(s)
      AC135721

    291. NM_001408436.1 → NP_001395365.1  breast cancer type 1 susceptibility protein isoform 111

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQF1

    292. NM_001408437.1 → NP_001395366.1  breast cancer type 1 susceptibility protein isoform 111

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQF1

    293. NM_001408438.1 → NP_001395367.1  breast cancer type 1 susceptibility protein isoform 111

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQF1

    294. NM_001408439.1 → NP_001395368.1  breast cancer type 1 susceptibility protein isoform 111

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQF1
      Related
      ENSP00000419481.2, ENST00000484087.6

    295. NM_001408440.1 → NP_001395369.1  breast cancer type 1 susceptibility protein isoform 111

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQF1

    296. NM_001408441.1 → NP_001395370.1  breast cancer type 1 susceptibility protein isoform 112

      Status: REVIEWED

      Source sequence(s)
      AC135721

    297. NM_001408442.1 → NP_001395371.1  breast cancer type 1 susceptibility protein isoform 112

      Status: REVIEWED

      Source sequence(s)
      AC135721

    298. NM_001408443.1 → NP_001395372.1  breast cancer type 1 susceptibility protein isoform 112

      Status: REVIEWED

      Source sequence(s)
      AC135721

    299. NM_001408444.1 → NP_001395373.1  breast cancer type 1 susceptibility protein isoform 112

      Status: REVIEWED

      Source sequence(s)
      AC135721

    300. NM_001408445.1 → NP_001395374.1  breast cancer type 1 susceptibility protein isoform 113

      Status: REVIEWED

      Source sequence(s)
      AC135721

    301. NM_001408446.1 → NP_001395375.1  breast cancer type 1 susceptibility protein isoform 113

      Status: REVIEWED

      Source sequence(s)
      AC135721

    302. NM_001408447.1 → NP_001395376.1  breast cancer type 1 susceptibility protein isoform 113

      Status: REVIEWED

      Source sequence(s)
      AC135721

    303. NM_001408448.1 → NP_001395377.1  breast cancer type 1 susceptibility protein isoform 113

      Status: REVIEWED

      Source sequence(s)
      AC135721

    304. NM_001408450.1 → NP_001395379.1  breast cancer type 1 susceptibility protein isoform 113

      Status: REVIEWED

      Source sequence(s)
      AC135721

    305. NM_001408451.1 → NP_001395380.1  breast cancer type 1 susceptibility protein isoform 114

      Status: REVIEWED

      Source sequence(s)
      AC135721

    306. NM_001408452.1 → NP_001395381.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7

    307. NM_001408453.1 → NP_001395382.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7

    308. NM_001408454.1 → NP_001395383.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7
      Related
      ENSP00000418819.2, ENST00000493919.6

    309. NM_001408455.1 → NP_001395384.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7

    310. NM_001408456.1 → NP_001395385.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7

    311. NM_001408457.1 → NP_001395386.1  breast cancer type 1 susceptibility protein isoform 115

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A2R8Y587, A0A9Y1QPT7

    312. NM_001408458.1 → NP_001395387.1  breast cancer type 1 susceptibility protein isoform 116

      Status: REVIEWED

      Source sequence(s)
      AC060780, AC135721
      UniProtKB/TrEMBL
      B4DES0

    313. NM_001408459.1 → NP_001395388.1  breast cancer type 1 susceptibility protein isoform 116

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      B4DES0

    314. NM_001408460.1 → NP_001395389.1  breast cancer type 1 susceptibility protein isoform 116

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      B4DES0

    315. NM_001408461.1 → NP_001395390.1  breast cancer type 1 susceptibility protein isoform 116

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      B4DES0

    316. NM_001408462.1 → NP_001395391.1  breast cancer type 1 susceptibility protein isoform 117

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQ47

    317. NM_001408463.1 → NP_001395392.1  breast cancer type 1 susceptibility protein isoform 117

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQ47

    318. NM_001408464.1 → NP_001395393.1  breast cancer type 1 susceptibility protein isoform 117

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQ47

    319. NM_001408465.1 → NP_001395394.1  breast cancer type 1 susceptibility protein isoform 117

      Status: REVIEWED

      Source sequence(s)
      AC135721
      UniProtKB/TrEMBL
      A0A9Y1QQ47

    320. NM_001408466.1 → NP_001395395.1  breast cancer type 1 susceptibility protein isoform 118

      Status: REVIEWED

      Source sequence(s)
      AC135721

    321. NM_001408467.1 → NP_001395396.1  breast cancer type 1 susceptibility protein isoform 118

      Status: REVIEWED

      Source sequence(s)
      AC135721

    322. NM_001408468.1 → NP_001395397.1  breast cancer type 1 susceptibility protein isoform 119

      Status: REVIEWED

      Source sequence(s)
      AC135721

    323. NM_001408469.1 → NP_001395398.1  breast cancer type 1 susceptibility protein isoform 120

      Status: REVIEWED

      Source sequence(s)
      AC135721

    324. NM_001408470.1 → NP_001395399.1  breast cancer type 1 susceptibility protein isoform 121

      Status: REVIEWED

      Source sequence(s)
      AC135721

    325. NM_001408472.1 → NP_001395401.1  breast cancer type 1 susceptibility protein isoform 122

      Status: REVIEWED

      Source sequence(s)
      AC135721

    326. NM_001408473.1 → NP_001395402.1  breast cancer type 1 susceptibility protein isoform 123

      Status: REVIEWED

      Source sequence(s)
      AC135721

    327. NM_001408474.1 → NP_001395403.1  breast cancer type 1 susceptibility protein isoform 124

      Status: REVIEWED

      Source sequence(s)
      AC135721

    328. NM_001408475.1 → NP_001395404.1  breast cancer type 1 susceptibility protein isoform 125

      Status: REVIEWED

      Source sequence(s)
      AC135721

    329. NM_001408476.1 → NP_001395405.1  breast cancer type 1 susceptibility protein isoform 126

      Status: REVIEWED

      Source sequence(s)
      AC135721

    330. NM_001408478.1 → NP_001395407.1  breast cancer type 1 susceptibility protein isoform 127

      Status: REVIEWED

      Source sequence(s)
      AC135721

    331. NM_001408479.1 → NP_001395408.1  breast cancer type 1 susceptibility protein isoform 127

      Status: REVIEWED

      Source sequence(s)
      AC135721

    332. NM_001408480.1 → NP_001395409.1  breast cancer type 1 susceptibility protein isoform 127

      Status: REVIEWED

      Source sequence(s)
      AC135721

    333. NM_001408481.1 → NP_001395410.1  breast cancer type 1 susceptibility protein isoform 128

      Status: REVIEWED

      Source sequence(s)
      AC135721

    334. NM_001408482.1 → NP_001395411.1  breast cancer type 1 susceptibility protein isoform 128

      Status: REVIEWED

      Source sequence(s)
      AC135721

    335. NM_001408483.1 → NP_001395412.1  breast cancer type 1 susceptibility protein isoform 128

      Status: REVIEWED

      Source sequence(s)
      AC135721

    336. NM_001408484.1 → NP_001395413.1  breast cancer type 1 susceptibility protein isoform 128

      Status: REVIEWED

      Source sequence(s)
      AC135721

    337. NM_001408485.1 → NP_001395414.1  breast cancer type 1 susceptibility protein isoform 128

      Status: REVIEWED

      Source sequence(s)
      AC135721

    338. NM_001408489.1 → NP_001395418.1  breast cancer type 1 susceptibility protein isoform 129

      Status: REVIEWED

      Source sequence(s)
      AC135721

    339. NM_001408490.1 → NP_001395419.1  breast cancer type 1 susceptibility protein isoform 130

      Status: REVIEWED

      Source sequence(s)
      AC135721

    340. NM_001408491.1 → NP_001395420.1  breast cancer type 1 susceptibility protein isoform 130

      Status: REVIEWED

      Source sequence(s)
      AC135721

    341. NM_001408492.1 → NP_001395421.1  breast cancer type 1 susceptibility protein isoform 131

      Status: REVIEWED

      Source sequence(s)
      AC135721

    342. NM_001408493.1 → NP_001395422.1  breast cancer type 1 susceptibility protein isoform 132

      Status: REVIEWED

      Source sequence(s)
      AC135721

    343. NM_001408494.1 → NP_001395423.1  breast cancer type 1 susceptibility protein isoform 133

      Status: REVIEWED

      Source sequence(s)
      AC135721

    344. NM_001408495.1 → NP_001395424.1  breast cancer type 1 susceptibility protein isoform 134

      Status: REVIEWED

      Source sequence(s)
      AC135721

    345. NM_001408496.1 → NP_001395425.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    346. NM_001408497.1 → NP_001395426.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    347. NM_001408498.1 → NP_001395427.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    348. NM_001408499.1 → NP_001395428.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    349. NM_001408500.1 → NP_001395429.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    350. NM_001408501.1 → NP_001395430.1  breast cancer type 1 susceptibility protein isoform 135

      Status: REVIEWED

      Source sequence(s)
      AC135721

    351. NM_001408502.1 → NP_001395431.1  breast cancer type 1 susceptibility protein isoform 136

      Status: REVIEWED

      Source sequence(s)
      AC135721

    352. NM_001408503.1 → NP_001395432.1  breast cancer type 1 susceptibility protein isoform 137

      Status: REVIEWED

      Source sequence(s)
      AC135721

    353. NM_001408504.1 → NP_001395433.1  breast cancer type 1 susceptibility protein isoform 137

      Status: REVIEWED

      Source sequence(s)
      AC135721

    354. NM_001408505.1 → NP_001395434.1  breast cancer type 1 susceptibility protein isoform 138

      Status: REVIEWED

      Source sequence(s)
      AC135721

    355. NM_001408506.1 → NP_001395435.1  breast cancer type 1 susceptibility protein isoform 139

      Status: REVIEWED

      Source sequence(s)
      AC135721

    356. NM_001408507.1 → NP_001395436.1  breast cancer type 1 susceptibility protein isoform 140

      Status: REVIEWED

      Source sequence(s)
      AC135721

    357. NM_001408508.1 → NP_001395437.1  breast cancer type 1 susceptibility protein isoform 141

      Status: REVIEWED

      Source sequence(s)
      AC135721

    358. NM_001408509.1 → NP_001395438.1  breast cancer type 1 susceptibility protein isoform 142

      Status: REVIEWED

      Source sequence(s)
      AC135721

    359. NM_001408510.1 → NP_001395439.1  breast cancer type 1 susceptibility protein isoform 143

      Status: REVIEWED

      Source sequence(s)
      AC135721

    360. NM_001408511.1 → NP_001395440.1  breast cancer type 1 susceptibility protein isoform 144

      Status: REVIEWED

      Source sequence(s)
      AC135721

    361. NM_001408512.1 → NP_001395441.1  breast cancer type 1 susceptibility protein isoform 145

      Status: REVIEWED

      Source sequence(s)
      AC135721

    362. NM_001408513.1 → NP_001395442.1  breast cancer type 1 susceptibility protein isoform 146

      Status: REVIEWED

      Source sequence(s)
      AC135721

    363. NM_001408514.1 → NP_001395443.1  breast cancer type 1 susceptibility protein isoform 147

      Status: REVIEWED

      Source sequence(s)
      AC135721

    364. NM_007294.4 → NP_009225.1  breast cancer type 1 susceptibility protein isoform 1

      See identical proteins and their annotated locations for NP_009225.1

      Status: REVIEWED

      Source sequence(s)
      AL701927, BC072418, BU617173, BU679389, U14680
      Consensus CDS
      CCDS11453.1
      UniProtKB/Swiss-Prot
      E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
      UniProtKB/TrEMBL
      A0A386INP3, A0A386IPK6, G8I0D8
      Related
      ENSP00000350283.3, ENST00000357654.9
      Conserved Domains (4) summary
      smart00292
      Location:1758 → 1842
      BRCT; breast cancer carboxy-terminal domain
      cd00027
      Location:1650 → 1724
      BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
      cd00162
      Location:23 → 68
      RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
      pfam12820
      Location:345 → 507
      BRCT_assoc; Serine-rich domain associated with BRCT

    365. NM_007297.4 → NP_009228.2  breast cancer type 1 susceptibility protein isoform 3

      Status: REVIEWED

      Source sequence(s)
      BC072418, BU617173, BU679389, U14680
      Consensus CDS
      CCDS11459.2
      UniProtKB/TrEMBL
      A0A386INP3, A0A9Y1QQK3
      Related
      ENSP00000418775.1, ENST00000493795.5
      Conserved Domains (3) summary
      smart00292
      Location:1711 → 1795
      BRCT; breast cancer carboxy-terminal domain
      cd00027
      Location:1603 → 1677
      BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
      pfam12820
      Location:298 → 460
      BRCT_assoc; Serine-rich domain associated with BRCT

    366. NM_007298.4 → NP_009229.2  breast cancer type 1 susceptibility protein isoform 4

      See identical proteins and their annotated locations for NP_009229.2

      Status: REVIEWED

      Source sequence(s)
      AC135721
      Consensus CDS
      CCDS11454.2
      UniProtKB/TrEMBL
      A0A9Y1QQL7
      Conserved Domains (3) summary
      smart00292
      Location:654 → 738
      BRCT; breast cancer carboxy-terminal domain
      cd00027
      Location:546 → 620
      BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
      cd00162
      Location:23 → 68
      RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...

    367. NM_007299.4 → NP_009230.2  breast cancer type 1 susceptibility protein isoform 5

      See identical proteins and their annotated locations for NP_009230.2

      Status: REVIEWED

      Source sequence(s)
      BC072418, BU617173, BU679389
      Consensus CDS
      CCDS11455.2
      UniProtKB/TrEMBL
      A0A9Y1QPQ7
      Related
      ENSP00000417148.1, ENST00000468300.5
      Conserved Domains (2) summary
      pfam00533
      Location:546 → 619
      BRCT; BRCA1 C Terminus (BRCT) domain
      cd16498
      Location:18 → 65
      RING-HC_BRCA1; RING finger, HC subclass, found in breast cancer type 1 susceptibility protein (BRCA1) and similar proteins

    368. NM_007300.4 → NP_009231.2  breast cancer type 1 susceptibility protein isoform 2

      Status: REVIEWED

      Source sequence(s)
      AC135721, BC072418, BC115037, BU617173, BU679389, U14680
      Consensus CDS
      CCDS11456.2
      UniProtKB/TrEMBL
      A0A386INP3, A0A386IPK6, G8I0D8
      Related
      ENSP00000418960.2, ENST00000471181.7
      Conserved Domains (4) summary
      smart00292
      Location:1779 → 1863
      BRCT; breast cancer carboxy-terminal domain
      cd00027
      Location:1671 → 1745
      BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
      cd00162
      Location:23 → 68
      RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
      pfam12820
      Location:345 → 507
      BRCT_assoc; Serine-rich domain associated with BRCT

    RefSeqs of Annotated Genomes: GCF_000001405.40-RS_2023_10

    The following sections contain reference sequences that belong to a specific genome build. Explain

    Reference GRCh38.p14 Primary Assembly

    Genomic

    1. NC_000017.11 Reference GRCh38.p14 Primary Assembly

      Range
      43044295..43170327 complement
      Download
      GenBank, FASTA, Sequence Viewer (Graphics)

    Alternate T2T-CHM13v2.0

    Genomic

    1. NC_060941.1 Alternate T2T-CHM13v2.0

      Range
      43902857..44029084 complement
      Download
      GenBank, FASTA, Sequence Viewer (Graphics)

    Suppressed Reference Sequence(s)

    The following Reference Sequences have been suppressed. Explain

    1. NM_007295.2: Suppressed sequence

      Description
      NM_007295.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.

    2. NM_007296.2: Suppressed sequence

      Description
      NM_007296.2: This RefSeq was permanently suppressed because there is no full-length transcript support for the exon combination of this variant.

    3. NM_007301.2: Suppressed sequence

      Description
      NM_007301.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.

    4. NM_007302.2: Suppressed sequence

      Description
      NM_007302.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.

    5. NM_007303.2: Suppressed sequence

      Description
      NM_007303.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.

    6. NM_007305.2: Suppressed sequence

      Description
      NM_007305.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.

    7. NM_007306.2: Suppressed sequence

      Description
      NM_007306.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.
    Nucleotide Protein
    Heading Accession and Version
    Protein Accession Links
    GenPept Link UniProtKB Link
    P38398.2 GenPept UniProtKB/Swiss-Prot:P38398

    Gene LinkOut

    The following LinkOut resources are supplied by external providers. These providers are responsible for maintaining the links.

    Chemical Information
    Medical
    Molecular Biology Databases
    Research Materials
    Tools
    Miscellaneous